DK0691342T3 - Hidtil ukendte benzopyranderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem - Google Patents

Hidtil ukendte benzopyranderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem

Info

Publication number: DK0691342T3
Authority: DK; Denmark
Prior art keywords: alkyl; halo; alkoxy; hydroxy; processes
Prior art date: 1994-07-06

Application number

DK95401607T

Other languages

English (en)

Inventor

Gilbert Lavielle

Thierry Dubuffet

Mark Millan

Adrian Newman-Tancredi

Original Assignee

Adir

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-06

Filing date

1995-07-05

Publication date

1999-11-08

1995-07-05 Application filed by Adir filed Critical Adir

1999-11-08 Application granted granted Critical

1999-11-08 Publication of DK0691342T3 publication Critical patent/DK0691342T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Addiction (AREA)
Anesthesiology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK95401607T 1994-07-06 1995-07-05 Hidtil ukendte benzopyranderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem DK0691342T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9408328A FR2722194B1 (fr)	1994-07-06	1994-07-06	Nouveaux derives de benzopyrane, leur procede de preparation et les compositions pharmacuetiques qui les contiennent

Publications (1)

Publication Number	Publication Date
DK0691342T3 true DK0691342T3 (da)	1999-11-08

Family

ID=9465049

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95401607T DK0691342T3 (da)	1994-07-06	1995-07-05	Hidtil ukendte benzopyranderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem

Country Status (16)

Country	Link
US (2)	US5663191A (da)
EP (1)	EP0691342B1 (da)
JP (1)	JP2999139B2 (da)
CN (1)	CN1049660C (da)
AT (1)	ATE179421T1 (da)
AU (1)	AU684165B2 (da)
CA (1)	CA2153195C (da)
DE (1)	DE69509308T2 (da)
DK (1)	DK0691342T3 (da)
ES (1)	ES2133686T3 (da)
FI (1)	FI111945B (da)
FR (1)	FR2722194B1 (da)
GR (1)	GR3030168T3 (da)
NO (1)	NO311085B1 (da)
NZ (1)	NZ272501A (da)
ZA (1)	ZA955631B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5891882A (en) *	1996-12-06	1999-04-06	Abbott Laboratories	Benzopyranopyrrole and benzopyranopyridine α-1 adenergic compounds
FR2764890B1 (fr) *	1997-06-24	1999-08-27	Adir	Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5919802A (en) *	1997-12-05	1999-07-06	Princeton University	Methods of preventing and/or treating temporal lobe epilepsy
AR022228A1 (es)	1999-01-12	2002-09-04	Abbott Gmbh & Co Kg	Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para la preparar dicha composicion
FR2823752B1 (fr) *	2001-04-18	2004-10-22	Servier Lab	Nouveaux derives de pyrimidin-4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB0118892D0 (en) *	2001-08-02	2001-09-26	Vernalis Res Ltd	Method of treatment
US20040053968A1 (en) *	2001-12-28	2004-03-18	Hartman George D.	Methods and compositions for treating peridontal disease
CN101120002A (zh) *	2005-02-17	2008-02-06	惠氏公司	环烷基稠合的吲哚、苯并噻吩、苯并呋喃和茚衍生物
BRPI0709880A2 (pt) *	2006-04-03	2011-07-26	Hoffmann La Roche	processo para preparaÇço e Ácidos carboxÍlicos cÍclicos beta-arÍlicos ou heteroarÍlicos e-nantiomericamente enriquecidos
TW200924752A (en) *	2007-09-17	2009-06-16	Organon Nv	Tricyclic heterocyclic derivatives
CA2744511A1 (en) *	2008-12-16	2010-06-24	F.Hoffmann-La Roche Ag	Process for the preparation of pyrollidine-3-carboxylic acids
FR2948372B1 (fr) *	2009-07-21	2011-07-22	Servier Lab	Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN105111220A (zh) *	2015-09-12	2015-12-02	浙江大学	取代1,4-二氢苯并吡喃[2,3-b]吡咯化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3518272A (en) *	1968-02-05	1970-06-30	Warner Lambert Pharmaceutical	Tetrahydro benzopyranoquinolines and process for their production
US3888946A (en) *	1971-03-17	1975-06-10	Little Inc A	Pyrano benzopyrans
AU560459B2 (en) *	1982-06-01	1987-04-09	Abbott Laboratories	Tetrahydro-benzo(e) isoindolines
US4666916A (en) *	1985-11-08	1987-05-19	Ciba-Geigy Corporation	Hexahydro-(1)-benzo-(pyrano and thiopyrano) (4,3-C)pyridines, useful as serotin-2 blocking agents
EP0422134B1 (en) *	1988-12-15	1996-06-12	Abbott Laboratories	5-ht selective agents
GB8917333D0 (en) *	1989-07-28	1989-09-13	Merck Sharp & Dohme	Therapeutic agents
FR2687146B1 (fr) *	1992-02-12	1994-04-01	Adir Cie	Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

1994
- 1994-07-06 FR FR9408328A patent/FR2722194B1/fr not_active Expired - Fee Related
1995
- 1995-07-04 AU AU24826/95A patent/AU684165B2/en not_active Ceased
- 1995-07-04 CA CA002153195A patent/CA2153195C/fr not_active Expired - Fee Related
- 1995-07-05 CN CN95109942A patent/CN1049660C/zh not_active Expired - Fee Related
- 1995-07-05 NZ NZ272501A patent/NZ272501A/en not_active IP Right Cessation
- 1995-07-05 DE DE69509308T patent/DE69509308T2/de not_active Expired - Lifetime
- 1995-07-05 DK DK95401607T patent/DK0691342T3/da active
- 1995-07-05 AT AT95401607T patent/ATE179421T1/de active
- 1995-07-05 EP EP95401607A patent/EP0691342B1/fr not_active Expired - Lifetime
- 1995-07-05 FI FI953308A patent/FI111945B/fi not_active IP Right Cessation
- 1995-07-05 ES ES95401607T patent/ES2133686T3/es not_active Expired - Lifetime
- 1995-07-05 US US08/498,217 patent/US5663191A/en not_active Expired - Lifetime
- 1995-07-05 NO NO19952660A patent/NO311085B1/no not_active IP Right Cessation
- 1995-07-06 JP JP7170635A patent/JP2999139B2/ja not_active Expired - Fee Related
- 1995-07-06 ZA ZA955631A patent/ZA955631B/xx unknown
1997
- 1997-01-21 US US08/786,504 patent/US5723484A/en not_active Expired - Lifetime
1999
- 1999-05-07 GR GR990401249T patent/GR3030168T3/el unknown

Also Published As

Publication number	Publication date
US5723484A (en)	1998-03-03
ATE179421T1 (de)	1999-05-15
US5663191A (en)	1997-09-02
CN1119189A (zh)	1996-03-27
EP0691342B1 (fr)	1999-04-28
JP2999139B2 (ja)	2000-01-17
FI953308A (fi)	1996-01-07
NO311085B1 (no)	2001-10-08
AU2482695A (en)	1996-01-18
EP0691342A1 (fr)	1996-01-10
CN1049660C (zh)	2000-02-23
DE69509308T2 (de)	1999-11-25
ES2133686T3 (es)	1999-09-16
GR3030168T3 (en)	1999-08-31
NO952660D0 (no)	1995-07-05
JPH0841066A (ja)	1996-02-13
CA2153195A1 (fr)	1996-01-07
ZA955631B (en)	1996-02-16
DE69509308D1 (de)	1999-06-02
NZ272501A (en)	1996-03-26
FI111945B (fi)	2003-10-15
NO952660L (no)	1996-01-08
AU684165B2 (en)	1997-12-04
CA2153195C (fr)	2004-06-15
FI953308A0 (fi)	1995-07-05
FR2722194B1 (fr)	1996-08-23
FR2722194A1 (fr)	1996-01-12

Publication	Publication Date	Title
DK0691342T3 (da)	1999-11-08	Hidtil ukendte benzopyranderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem
TR199902995T2 (xx)	2000-02-21	9-Oksim eritromisin t�revleri
MX9602837A (es)	1997-06-28	Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados.
BG103518A (en)	2000-01-31	2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives
EA199901015A1 (ru)	2000-06-26	4"-замещенные производные 9-деоксо-9а-а3а-9а-гомоэритромицина а
DK537289D0 (da)	1989-10-27	4h-1-benzopyran-4-on-derivater, deres fremstilling og anvendelse
EP0767170A4 (en)	1998-08-05	4,6-DIARYLPYRIMIDINE DERIVATIVES AND THEIR SALTS
DK91692A (da)	1992-07-14	Halogenerede nucleosidderivater, saadanne forbindelser til anvendelse mod en adenovirusinfektion, anvendelse af forbindelserne til fremstilling af et laegemiddel mod en adenovirusinfektion, farmaceutiske praeparater indeholdende forbindelserne samt fremgangsmaade til fremstilling af forbindelserne
DK0486386T3 (da)	1996-11-25	Hidtil ukendte N-benzoylprolinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES8308567A1 (es)	1983-09-16	Procedimiento para la preparacion de derivados de penem.
IL112102A0 (en)	1995-03-15	Annelated dihydropyridinoacetic acid derivatives, their preparation and pharmaceutical compositions containing them
NO880406L (no)	1988-08-01	5-(3-alkyl-5-tert-butyl-4-hydroksyfenyl)-2-amino-6h-1,3,4-tiadiaziner, fremgangsmaate til deres fremstilling og legemidler som inneholder dem og deres anvendelse.
NO972943L (no)	1997-12-29	4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende dem og deres anvendelse
FR2596760B1 (fr)	1988-12-09	Derives dissymetriques de l'acide 1,4-dihydropyridine-3,5-dicarboxylique, procedes de preparation et utilisation en therapeutique
IL61911A (en)	1983-10-31	2,3-dihydro-imidazo(1,2-b)pyridazine derivatives,their preparation and pharmaceutical compositions containing them
TNSN98061A1 (fr)	2005-03-15	Derives d'erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
NO911508L (no)	1991-04-17	Nytt s-timololderivat og fremgangsmaate for dets fremstilling.
NO306300B1 (no)	1999-10-18	3-alkoksykarbonyltiadiazinoner, farmasöytiske preparater som inneholder minst èn slik forbindelse, og anvendelse av forbindelsene til fremstilling av legemidler
DK0574312T3 (da)	1995-04-10	Diacylglycerolnicotinater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
IL81258A (en)	1991-06-10	Dihydropyridinelactols,their preparation and pharmaceutical compositions containing them
DK48489D0 (da)	1989-02-02	Heteroanellerede phenylglycin-beta-lactam-antibiotika og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
FI890173A0 (fi)	1989-01-13	Isoxazoler med nootropisk verkan.